| Literature DB >> 26935205 |
Elizabeth R Gleim1,2,3, Laurel E Garrison4,5, Marianne S Vello6, Mason Y Savage7,8, Gaylord Lopez9, Roy D Berghaus10, Michael J Yabsley11,12.
Abstract
BACKGROUND: The incidence and emergence of tick-borne diseases has increased dramatically in the United States during the past 30 years, yet few large-scale epidemiological studies have been performed on individuals bitten by ticks. Epidemiological information, including disease development, may provide valuable information regarding effectiveness of tick bite prevention education, pathogen transmission, human-disease dynamics, and potential implications for under reporting of tick-borne diseases.Entities:
Mesh:
Year: 2016 PMID: 26935205 PMCID: PMC4776404 DOI: 10.1186/s13071-016-1408-6
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Polymerase chain reaction protocols used for testing ticks for selected pathogens
| Pathogen | Gene Target/Reference | Primers | Annealing Temperature |
|---|---|---|---|
| Primary/Secondary | |||
|
| 16S rRNA/[ | Primary: ECC (5′-AGAACGAACGCTGGCGGCAAGCC) | 55 °C/55 °C |
| Primary: ECB (5′-CGTATTACCGCGGCTGCTGGCA) | |||
| Secondary: HE1 (5′-CAATTGCTTATAACCTTTTGGTTATAAAT) | |||
| Secondary: HE3 (5′-TATAGGTACCGTCATTATCTTCCCTAT) | |||
|
| 16S rRNA/[ | Primary: ECC (5′-AGAACGAACGCTGGCGGCAAGCC) | 55 °C/48 °C |
| Primary: ECB (5′-CGTATTACCGCGGCTGCTGGCA-3′) | |||
| Secondary: HE3 (5′-TATAGGTACCGTCATTATCTTCCCTAT-3′) | |||
| Secondary: EE72 (5′-CAATTCCTAAATAGTCTCTGACTATT-3′) | |||
|
| 17-kDa antigen/[ | Primary: 17kD1 (5′-GCTCTTGCAACTTCTATGTT-3′) | 48 °C/48 °C |
| Primary: 17kD2 (5′-CATTGTTCGTCAGGTTGGCG-3′) | |||
| Secondary: 17 k-5 (5′-GCTTTACAAAATTCTAAAAACCATATA) | |||
| Secondary: 17 k-3 (5′-TGTCTATCAATTCACAACTTGCC) | |||
|
| Flagellin ( | Primary: FLALL (5′-ACATATTCAGATGCAGACAGAGGT) | 55 °C/55 °C |
| Primary: FLARL (5′-GCAATCATAGCCATTGCAGATTGT) | |||
| Secondary: FLALS (5′-AACAGCTGAAGAGCTTGGAATG) | |||
| Secondary: FLARS (5′-CTTTGATCACTTATCATTCTAATAGC) | |||
|
| FopA/[ | Primary: FNA8L (5′-CGAGGAGTCTCAATGTACTAAGGTTTGCCC) | 55 °C/55 °C |
| Primary: FNB2L (5′-CACCATTATCCTGGATATTACCAGTGTCAT) | |||
| Secondary: FNA7L (5′-CTTGAGTCTTATGTTTCGGCATGTGAATAG) | |||
| Secondary: FNB1L (5′-CCAACTAATTGGTTGTACTGTACAGCGAAG) |
Summary of ticks collected by species, life stage, and polymerase chain reaction (PCR) assay results
| Tick species | Stage | No. |
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
| No. ticks positive (% total ticks) | ||||||||
|
| Adulta | 241 | 1 (0.4) | 2 (0.8) | 76 (32) |
| ||
|
| ||||||||
|
| ||||||||
|
| ||||||||
|
| ||||||||
| Nymph | 185 | 46 (25) |
| |||||
|
| ||||||||
|
| Adult | 18 | 4 (22) |
| ||||
|
| ||||||||
|
| ||||||||
|
| ||||||||
| Nymph | 1 | 1 (100) |
| |||||
|
| Nymph | 3 | 2 (67) |
| ||||
|
| Adulta | 142 | 2 (1) | 1 (0.7) | 18 (13) |
| ||
|
| ||||||||
|
| ||||||||
|
| Adult | 7 | 6 (86) |
| ||||
|
| ||||||||
|
| ||||||||
aOne was co-infected
Fig. 1Georgia state map of total submissions per 10,000 residents by county. Note that map denotes participants’ resident county, not necessarily where the tick was acquired. Red dots indicate counties where ticks were acquired (not necessarily individual’s county of residence) that resulted in an illness that fit criteria for a potential tick-borne disease
Fig. 2Maps with numbers of ticks by species originating from each county in Georgia. a. = A. americanum, b. = D. variabilis, c. = A. maculatum, and d. = I. scapularis
Associations between protective measures against tick bites and illness, gender, and proximity to home residence
| Illness After Tick Bite (%) | Gender (%) | Location When Bitten (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Sick | Not Sick |
| Male | Female |
| Away from Home | At Home | Unknown |
| |
| No Primary a( | 5 (36) | 9 (64) | 0.29 | 9 (64) | 5 (36) | 0.52 | 2 (14) | 11 (78) | 1 (8) | 0.18 |
| Primary ( | 11 (20) | 44 (80) | 27 (49) | 28 (51) | 27 (49) | 19 (35) | 9 (16) | |||
| No Secondary a( | 5 (50) | 5 (50) | 0.04 | 4 (40) | 6 (60) | 0.19 | 5 (50) | 5 (50) | 0 | 0.4 |
| Secondary Protection ( | 11 (19) | 48 (81) | 32 (54) | 27 (46) | 24 (41) | 25 (42) | 10 (17) | |||
a5 participants using neither primary nor secondary protection declined to answer questions related to illness, gender or location when bitten
bNote that 12 of 55 and 25 of 59 individuals took primary and secondary protection measures respectively
Description of participants who submitted a tick positive for a species of pathogenic bacteria
| Participant # | Tick Species | Pathogen | Time Attached (hrs) | Incubation, if applicable (days) | Went to Doctor | Symptoms |
|---|---|---|---|---|---|---|
| 1 |
|
| unknown | 4 | yes | fever, rash, weakness, myalgia, joint pain, congested, earache, swollen & runny eyes |
| 2 |
|
| 6-12 | <1 | yes | tight neck |
| 3 |
| Panola Mountain | 2-6 | n/a | no | not sick |
| 4 |
|
| 1-4 | 13 | no | nausea, fever, chills, stomach pain, weakness, headache, joint pain, sweats, cough |
| 5 |
|
| unknown | n/a | no | not sick |
Univariate analysis of potential risk factors for non-specific illness after a tick bite
| Variable |
| # Sick (%) |
a
|
|---|---|---|---|
| Time Attached (hrs) | 0.032 | ||
| 1-12 | 196 | 26 (13.3) | |
| 12-24 | 68 | 16 (23.5) | |
| 24-48 | 39 | 12 (30.8) | |
| >48 | 33 | 6 (18.2) | |
| Secondary | 0.045 | ||
| yes | 59 | 11 (18.6) | |
| no | 10 | 5 (50.0) | |
| Pathogenic Bacteria Positive | 0.048 | ||
| yes | 5 | 3 (60.0) | |
| no | 406 | 74 (18.2) |
aFisher’s exact test of independence
Participants with missing information were excluded from statistical comparisons
Description of participants meeting criteria for having a potential tick-borne illness
| Patient | Time Attached (hrs) | Incubation (days) | Days Sick | Symptomsa | Went to Doctor/Blood Drawn | Medicine Prescribed (if any) | Species (stage) | Engorged | Pathogen (s) |
|---|---|---|---|---|---|---|---|---|---|
| 2 | 6-12 | 0 | 2 |
| yes/no | clarithromycin |
| no |
|
| 6 | unknown | 6 | unknown |
| no | none |
| partially |
|
| 7 | 6-12 | 12 | 1 |
| no | none |
| no |
|
| 8 | >48 | 11 | 2 |
| no | none |
| partially |
|
| 9 | unknown | unknown | 14 |
| yes/no | doxycycline | 7 | no | 1 |
| 10 | 24-48 | 5 | 21 |
| yes/yes | doxycycline | 7 | no | 4 |
| 11 | >48 | 17 | 6 |
| no | none | 2 | no | 1 |
| 12 | 24-48 | 1 | 14 |
| yes/no | unknown topical cream | 2 | no | 1 |
| 13 | 24-48 | 5 | 7 |
| yes/yes | tetracycline |
| unknown | R. amblyommii |
| 14 | 12-24 | 26 | 2 |
| no | none |
| partially |
|
| 15 | unknown | 15 | unknown |
| no | none |
| no |
|
| 16 | 24-48 | 4 | unknown |
| no | none |
| no |
|
afirst symptom (s) in bold